Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share (ROIV)

Historical Holders from Q4 2021 to Q1 2025

Symbol
ROIV on Nasdaq
CUSIP
G76279101
Type / Class
Equity / Common shares, par value $0.0000000341740141 per share
Shares outstanding
714M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
562M
Holdings value
$6.65B
% of all portfolios
0.021%
Grand Portfolio weight change
0%
Number of holders
313
Number of buys
138
Number of sells
-143
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share (ROIV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QVT Financial LP 9.22% $664M 65.8M QVT Financial LP Dec 31, 2024
SB INVESTMENT ADVISERS (UK) LTD 8.5% $626M 62.1M SB Investment Advisers (UK) Limited Dec 31, 2024

Institutional Holders of Roivant Sciences Ltd. - Common shares, par value $0.0000000341740141 per share (ROIV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 2.17M $21.9M -$377K $10.09 29
2024 Q4 562M $6.65B -$34.6M $11.83 313
2024 Q3 565M $6.52B +$177M $11.54 294
2024 Q2 546M $5.77B +$197M $10.57 295
2024 Q1 527M $5.56B -$345M $10.54 257
2023 Q4 541M $6.08B -$174M $11.23 219
2023 Q3 543M $6.34B +$505M $11.68 201
2023 Q2 497M $5.01B +$399M $10.08 176
2023 Q1 459M $3.39B +$348M $7.38 142
2022 Q4 412M $3.29B +$287M $7.99 107
2022 Q3 371M $1.19B +$30.8M $3.22 74
2022 Q2 360M $1.47B +$45.7M $4.07 70
2022 Q1 349M $1.72B +$48.2M $4.94 49
2021 Q4 339M $3.42B +$3.37B $10.08 40